Uncategorized

FDA Seeks Expanded Authority To Regulate Postapproval Manufacturing Changes

FDA Seeks Expanded Authority To Regulate Postapproval Manufacturing Changes

Published

on

Aiming to protect patients, the FDA sent lawmakers a wish list of legislative proposals intended to clarify and expand its oversight of updates to approved drug production processes.​ ​Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version